Reported positive data updates from its ongoing Phase 2a trial of lead program IMM-1-104, including encouraging responses in combination with ...

Results from Phase 2a Trial demonstrate a good safety and tolerability profile of VXM01 and Avelumab Combination Therapy in Glioblastoma, supporting further ...

He introduced a bill in 2022, a modified version of the Farm Workforce Modernization Act, to overhaul the H-2A program. The bill built on House-passed legislation to expand the program to fill ...

Reported positive data updates from its ongoing Phase 2a trial of lead program IMM-1-104, including encouraging responses in combination with chemotherapy in first-line pancreatic cancer - - Announced ...

Treatment with VXM01, an investigational vaccine, plus Bavencio demonstrated both safety and tolerability in patients with ...

Industry veteran brings extensive oncology drug development expertise and experience in clinical treatment of cancer patients Dr. Matushansky ...

MELBOURNE -- Formula 1 's main feeder series, Formula 2, has been rocked by a cheating scandal on the eve of the new season, ...

Every year, the US issues 65,000 H-1B visas with an additional 20,000 for applicants with US master's degrees, and nearly 70 ...

In an alopecia areata trial, a novel bifunctional therapy that blocks signaling of the interleukin-7 and TSLP pathways produced impressive improvements in hair regrowth during and after therapy.

William Blair reiterated their outperform rating on shares of Alto Neuroscience (NYSE:ANRO – Free Report) in a report issued ...

All three teams have been fined €10,000 per car, and the FIA also decided that both cars in each team will serve a ...